The Medicines Company Supports Landmark Patient Observational Study And Clinical Survey On Acute Severe Hypertension

... The Medicines Company (Nasdaq: MDCO) today announced its support of two landmark initiatives on acute severe hypertension: a first-of-its-kind patient observational study (registry) to be conducted by The Center for Outcomes Research, University of Massachusetts Medical School and a large-scale clinical survey to be conducted by The Ohio State University. [click link for full article] ...